Five Prime Therapeutics, Inc. (NASDAQ: FPRX) announced today a corporate restructuring to extend the company’s cash runway without impacting or ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE